Evidence map›Paper›PMID 35027317›Full record

ArticleJournal of optometry

Optometry research in Spain: Topics of interest, institutions and investigators.

Genis Cardona, Laura Puigdueta-Carrera, Nathan Efron

Abstract read
In one paragraph

Article in Journal of optometry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Genis CardonaDepartment of Optics and Optometry, Universitat Politècnica de Catalunya, Terrassa, Spain. Electronic address: genis.cardona@upc.edu.
Laura Puigdueta-CarreraDepartment of Optics and Optometry, Universitat Politècnica de Catalunya, Terrassa, Spain.
Nathan EfronSchool of Optometry and Vision Science, Queensland University of Technology, Kelvin Grove, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo determine the institutions, journals of choice and topics of investigation of the most prolific and highly cited Spanish optometrist researchers.

methodsAs a primary search strategy, the Scopus database (Elsevier) was queried with the terms (optometr* OR "contact lens*" OR refracti* OR *ocular) and the affiliation country filter "Spain". The list of authors returned by the primary search was used in a secondary manual search based on co-authors and institutions. Authors were included in the analysis if they had an h-index > 10, were of Spanish nationality, were affiliated to Spanish institutions, and possessed an optometry degree. Authors were ranked by h-index, number of publications and number of citations. Topics of research interest and target journals were determined by analyzing the 10 most highly cited papers of each author.

resultsA total of 32 authors with an h-index > 10 were identified, of whom 14 (43.7%) were female. Only one author had an h-index > 40, and 7 (21.9%) authors had an h-index over 20. The Journal of Cataract and Refractive Surgery was the first journal of choice (19.1% of highest cited papers), followed by Optometry and Vision Science (10.3%). The Universidad Complutense de Madrid hosted the largest percentage of authors (18.7%), followed by the Universitat de València (15.6%). Main topics of research interest were topography (6.5% of papers), cornea (6.2%) and contact lens (5.0%).

conclusionOptometry in Spain is a fertile field of research, with an increasing number of highly cited authors publishing in high impact journals.

Indexed as

OphthalmologyOptometryBibliometricsFemaleHumansMaleSpainVision, OcularBibliometric analysisH-indexOptometryPublication metricsResearch

Identifiers

PMID35027317
PMCPMC10104787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.